G-protein Coupled Receptors (GPCRs): A Potential Target of Apigenin as a Novel hACE2 Receptor Specific Therapeutic for Impeding Lung Cancer Considering a Group of Missense and Nonsense Mutations in COVID-19 Patients. (2025). European Journal of Pharmaceutical Research, 5(1), 6-15. https://doi.org/10.24018/ejpharma.2025.5.1.85